Follow The Filings

TMCI Treace Medical Concepts

Treace Medical Concepts earnings company data as of 7:50 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 5 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by TMCI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All TMCI insider trades
  • $1.2M bought by 1 insider
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. John T. Treace CEO
    Buy
    $247K 55,944 shares at $4.41 +0.8% to stake
    Traded Aug 20–24 Filed Aug 24
    ↗
  2. John T. Treace CEO
    Buy
    $99K 24,606 shares at $4.03 +0.3% to stake
    Traded Jun 10–11 Filed Jun 12
    ↗
  3. John T. Treace CEO
    Buy
    $178K 50,000 shares at $3.56 +0.7% to stake
    Traded Jun 1 Filed Jun 1
    ↗
  4. John T. Treace CEO
    Buy
    $341K 115,520 shares at $2.95 +1.6% to stake
    Traded May 26–28 Filed May 28
    ↗
  5. John T. Treace CEO
    Buy
    $376K 153,763 shares at $2.44 +2.2% to stake
    Traded May 12–14 Filed May 14
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 share withholdings for taxes, 12 stock grants, and 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,5.02,7.01 Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.